Suppr超能文献

踝臂指数、血管钙化与透析患者的死亡率。

Ankle--brachial index, vascular calcifications and mortality in dialysis patients.

机构信息

Diaverum, Unidade do Estoril, Portugal.

出版信息

Nephrol Dial Transplant. 2012 Jan;27(1):318-25. doi: 10.1093/ndt/gfr233. Epub 2011 May 6.

Abstract

BACKGROUND

The ankle-brachial index (ABI) is a noninvasive method to evaluate peripheral artery disease (PAD). ABI <0.9 diagnoses PAD; ABI >1.3 is a false negative caused by noncompressible arteries. The aim of this study is to evaluate the association between ABI with vascular calcifications (VC) and with mortality, in haemodialysis (HD) patients.

METHODS

We studied 219 HD patients (60% male; 20% diabetic). At baseline, ABI was evaluated by a Doppler device. VCs were evaluated by two methods: the abdominal aorta calcification score (AACS) in a lateral plain X-ray of the abdominal aorta and the simple vascular calcification score (SVCS) in plain X-rays of the pelvis and hands. VC were also classified by their anatomical localization in main vessels (aorta and iliac-femoral axis) and in peripheral or distal vessels (pelvic, radial or digital). The cutoff values for the different VC scores in relation with ABI were determined by receiver operating characteristic curve analysis. Biochemical parameters were time averaged for the 6 months preceding ABI evaluation.

RESULTS

An ABI <0.9, an ABI >1.3 or a normal ABI were found, respectively, in 90 (41%), in 42 (19%) and in 87 (40%) patients. AACS ≥6 and SVCS >3 were found, respectively, in 98 (45%) and 95 (43%) patients. The adjusted odds ratio (OR) for having an ABI <0.9 was 2.5 (P = 0.007) for AACS ≥6 and 4.5 (P < 0.001) for iliac-femoral calcification score (CS) ≥2. The adjusted OR for having an ABI >1.3 was 4.2 (P = 0.003) for pelvic CS and 3.7 (P = 0.006) for hand CS ≥2. During an observational period of 28.9 months, all-cause and cardiovascular mortality occurred, respectively, in 50 (23%) and in 29 (13%) patients. Adjusting for age, diabetes, P levels, HD duration and cardiovascular disease at baseline, an ABI <0.9 [hazard ratio (HR) = 3.9, P < 0.001] and an ABI >1.3 (HR = 2.7, P = 0.038) were associated with all-cause mortality; an ABI <0.9 (HR = 7.2, P = 0.002) and an ABI >1.3 (HR = 5.1, P = 0.028) were associated with cardiovascular mortality.

CONCLUSIONS

Both low and high ABI were independent predictors of all-cause and cardiovascular mortality. VC in main arteries were associated with an ABI <0.9. VC in peripheral and distal arteries were associated with an ABI >1.3. ABI is a simple and noninvasive method that allows the identification of high cardiovascular risk patients.

摘要

背景

踝臂指数(ABI)是一种评估外周动脉疾病(PAD)的非侵入性方法。ABI<0.9 诊断为 PAD;ABI>1.3 是由不可压缩动脉引起的假阴性。本研究旨在评估 ABI 与血管钙化(VC)以及与死亡率之间的相关性,在血液透析(HD)患者中。

方法

我们研究了 219 名 HD 患者(60%为男性;20%为糖尿病患者)。在基线时,使用多普勒设备评估 ABI。通过两种方法评估 VC:腹主动脉钙化评分(AACS)在腹主动脉的侧位 X 光片上和简单血管钙化评分(SVCS)在骨盆和手部的 X 光片上。VC 也根据其在主要血管(主动脉和髂股轴)和周围或远端血管(骨盆、桡骨或数字)中的解剖定位进行分类。通过接收者操作特征曲线分析确定与 ABI 相关的不同 VC 评分的截断值。生化参数在 ABI 评估前的 6 个月内进行时间平均。

结果

分别在 90 名(41%)、42 名(19%)和 87 名(40%)患者中发现 ABI<0.9、ABI>1.3 或正常 ABI。分别在 98 名(45%)和 95 名(43%)患者中发现 AACS≥6 和 SVCS>3。ABI<0.9 的调整后优势比(OR)为 2.5(P=0.007),对于 AACS≥6 和髂股 CS≥2 的 OR 为 4.5(P<0.001)。ABI>1.3 的调整后 OR 为骨盆 CS≥2 的 4.2(P=0.003)和手部 CS≥2 的 3.7(P=0.006)。在 28.9 个月的观察期内,分别有 50 名(23%)和 29 名(13%)患者发生全因和心血管死亡。在调整年龄、糖尿病、P 水平、HD 持续时间和基线时的心血管疾病后,ABI<0.9(HR=3.9,P<0.001)和 ABI>1.3(HR=2.7,P=0.038)与全因死亡率相关;ABI<0.9(HR=7.2,P=0.002)和 ABI>1.3(HR=5.1,P=0.028)与心血管死亡率相关。

结论

低 ABI 和高 ABI 都是全因和心血管死亡率的独立预测因素。主脉中的 VC 与 ABI<0.9 相关。周围和远端血管中的 VC 与 ABI>1.3 相关。ABI 是一种简单、非侵入性的方法,可以识别心血管风险较高的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验